CVS Health Corporation
CVS
NYSE
$92.72
-$1.30-1.38%
Volume3,564,879
05/19/2022 1:35PM Eastern
Quotes delayed
| 03/31/2022 | 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | |
|---|---|---|---|---|---|
| Revenue | 76.66B | 76.24B | 73.55B | 72.33B | 68.80B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 76.66B | 76.24B | 73.55B | 72.33B | 68.80B |
| Cost of Revenue | 63.46B | 62.95B | 61.09B | 59.42B | 56.60B |
| Gross Profit | 13.20B | 13.29B | 12.46B | 12.91B | 12.20B |
| SG&A Expenses | 9.39B | 10.17B | 9.19B | 8.83B | 8.88B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 72.85B | 73.13B | 70.28B | 68.25B | 65.48B |
| Operating Income | 3.81B | 3.11B | 3.27B | 4.08B | 3.32B |
| Income Before Tax | 2.95B | 1.57B | 2.15B | 3.74B | 2.97B |
| Income Tax Expenses | 633.00M | 274.00M | 558.00M | 944.00M | 746.00M |
| Earnings from Continuing Operations | 2.31B | 1.30B | 1.59B | 2.79B | 2.22B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.00M | 10.00M | 11.00M | -8.00M | -1.00M |
| Net Income | 2.31B | 1.31B | 1.60B | 2.78B | 2.22B |
| EBIT | 3.81B | 3.11B | 3.27B | 4.08B | 3.32B |
| EBITDA | 4.86B | 4.23B | 4.40B | 5.22B | 4.45B |
| EPS Basic | 1.76 | 0.99 | 1.21 | 2.11 | 1.69 |
| Normalized Basic EPS | 1.63 | 1.30 | 1.41 | 1.78 | 1.43 |
| EPS Diluted | 1.74 | 0.98 | 1.20 | 2.10 | 1.68 |
| Normalized Diluted EPS | 1.61 | 1.28 | 1.40 | 1.77 | 1.42 |
| Average Basic Shares Outstanding | 1.31B | 1.32B | 1.32B | 1.32B | 1.31B |
| Average Diluted Shares Outstanding | 1.33B | 1.34B | 1.33B | 1.33B | 1.32B |
| Dividend Per Share | 0.55 | 0.50 | 0.50 | 0.50 | 0.50 |
| Payout Ratio | 31.23% | 50.54% | 41.24% | 23.36% | 29.51% |
